Walker-Warburg congenital muscular dystrophy
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The findings of this study expand the clinical and pathologic spectrum of DGP associated with POMGNT2 variants from the severest Walker-Warburg syndrome to the mildest LGMD phenotypes.
|
27066570 |
2015 |
Walker-Warburg congenital muscular dystrophy
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
Using the antibody, we show that mutations of GTDC2 identified in Walker-Warburg syndrome and alanine-substitution of conserved residues between GTDC2 and EGF domain O-GlcNAc transferase resulted in decreased glycosylation.
|
24041696 |
2013 |
Walker-Warburg congenital muscular dystrophy
|
0.620 |
Biomarker
|
disease |
BEFREE |
We found that gtdc2 knockdown in zebrafish replicates all WWS features (hydrocephalus, ocular defects, and muscular dystrophy), strongly suggesting that GTDC2 mutations cause WWS.
|
22958903 |
2012 |
Walker-Warburg congenital muscular dystrophy
|
0.620 |
GermlineCausalMutation
|
disease |
ORPHANET |
We found that gtdc2 knockdown in zebrafish replicates all WWS features (hydrocephalus, ocular defects, and muscular dystrophy), strongly suggesting that GTDC2 mutations cause WWS.
|
22958903 |
2012 |
Walker-Warburg congenital muscular dystrophy
|
0.620 |
Biomarker
|
disease |
CTD_human |
|
|
|
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Milder forms of muscular dystrophy associated with POMGNT2 mutations.
|
27066570 |
2015 |
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome.
|
22958903 |
2012 |
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome.
|
22958903 |
2012 |
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome.
|
22958903 |
2012 |
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8
|
0.400 |
GeneticVariation
|
disease |
UNIPROT |
Milder forms of muscular dystrophy associated with POMGNT2 mutations.
|
27066570 |
2015 |
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Muscular Dystrophies, Limb-Girdle
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
The findings of this study expand the clinical and pathologic spectrum of DGP associated with POMGNT2 variants from the severest Walker-Warburg syndrome to the mildest LGMD phenotypes.
|
27066570 |
2015 |
Fukuyama Type Congenital Muscular Dystrophy
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Muscle eye brain disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
alpha-Dystroglycanopathies
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hydrocephalus
|
0.110 |
Biomarker
|
disease |
BEFREE |
We found that gtdc2 knockdown in zebrafish replicates all WWS features (hydrocephalus, ocular defects, and muscular dystrophy), strongly suggesting that GTDC2 mutations cause WWS.
|
22958903 |
2012 |
Muscular Dystrophy
|
0.110 |
Biomarker
|
disease |
BEFREE |
We found that gtdc2 knockdown in zebrafish replicates all WWS features (hydrocephalus, ocular defects, and muscular dystrophy), strongly suggesting that GTDC2 mutations cause WWS.
|
22958903 |
2012 |
Hydrocephalus
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Muscular Dystrophy
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Leukemia, Myelocytic, Acute
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
Malaria
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide and fine-resolution association analysis of malaria in West Africa.
|
19465909 |
2009 |
Anophthalmos
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|